progyny inc - PGNY

PGNY

Close Chg Chg %
25.48 0.38 1.49%

Closed Market

25.86

+0.38 (1.49%)

Volume: 1.23M

Last Updated:

Jun 5, 2026, 4:00 PM EDT

Company Overview: progyny inc - PGNY

PGNY Key Data

Open

$25.47

Day Range

25.19 - 26.09

52 Week Range

16.10 - 28.75

Market Cap

$2.00B

Shares Outstanding

78.33M

Public Float

69.43M

Beta

1.03

Rev. Per Employee

N/A

P/E Ratio

33.09

EPS

$0.81

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.78M

 

PGNY Performance

1 Week
 
1.17%
 
1 Month
 
9.02%
 
3 Months
 
41.23%
 
1 Year
 
19.28%
 
5 Years
 
-59.10%
 

PGNY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 11
Full Ratings ➔

About progyny inc - PGNY

Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm’s network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.

PGNY At a Glance

Progyny, Inc.
1359 Broadway
New York, New York 10018
Phone 1-212-888-3124 Revenue 1.29B
Industry Miscellaneous Commercial Services Net Income 58.52M
Sector Commercial Services 2025 Sales Growth 10.404%
Fiscal Year-end 12 / 2026 Employees 856
View SEC Filings

PGNY Valuation

P/E Current 33.091
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 39.435
Price to Sales Ratio 1.791
Price to Book Ratio 4.149
Price to Cash Flow Ratio 10.98
Enterprise Value to EBITDA 22.447
Enterprise Value to Sales 1.572
Total Debt to Enterprise Value 0.014

PGNY Efficiency

Revenue/Employee 1,505,445.093
Income Per Employee 68,364.486
Receivables Turnover 5.85
Total Asset Turnover 1.892

PGNY Liquidity

Current Ratio 2.726
Quick Ratio 2.726
Cash Ratio 1.532

PGNY Profitability

Gross Margin 23.628
Operating Margin 6.617
Pretax Margin 7.406
Net Margin 4.541
Return on Assets 8.593
Return on Equity 12.476
Return on Total Capital 10.762
Return on Invested Capital 11.961

PGNY Capital Structure

Total Debt to Total Equity 5.373
Total Debt to Total Capital 5.099
Total Debt to Total Assets 3.697
Long-Term Debt to Equity 4.651
Long-Term Debt to Total Capital 4.414
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Progyny Inc - PGNY

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
786.91M 1.09B 1.17B 1.29B
Sales Growth
+57.19% +38.34% +7.22% +10.40%
Cost of Goods Sold (COGS) incl D&A
619.59M 849.80M 913.86M 984.18M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.60M 2.28M 3.17M 4.95M
Depreciation
1.10M 2.20M 3.10M 4.10M
Amortization of Intangibles
501.00K 81.00K 75.00K 848.00K
COGS Growth
+59.49% +37.16% +7.54% +7.69%
Gross Income
167.32M 238.80M 253.36M 304.48M
Gross Income Growth
+49.22% +42.72% +6.10% +20.18%
Gross Profit Margin
+21.26% +21.94% +21.71% +23.63%
2022 2023 2024 2025 5-year trend
SG&A Expense
143.98M 176.62M 185.91M 219.21M
Research & Development
- - - -
-
Other SG&A
143.98M 176.62M 185.91M 219.21M
SGA Growth
+80.44% +22.66% +5.26% +17.91%
Other Operating Expense
- - - -
-
Unusual Expense
- - (3.90M) (7.30M)
-
EBIT after Unusual Expense
23.34M 66.08M 74.75M 85.28M
Non Operating Income/Expense
1.10M 4.61M 9.98M 10.55M
Non-Operating Interest Income
- - 814.00K 3.30M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - 1.53M 400.00K
-
Interest Expense Growth
- - - -73.94%
-
Gross Interest Expense
- - 1.53M 400.00K
-
Interest Capitalized
- - - -
-
Pretax Income
24.44M 70.69M 83.20M 95.43M
Pretax Income Growth
-24.65% +189.23% +17.70% +14.70%
Pretax Margin
+3.11% +6.49% +7.13% +7.41%
Income Tax
(5.92M) 8.65M 28.87M 36.91M
Income Tax - Current - Domestic
695.00K 4.91M 39.32M 45.03M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(6.61M) 3.75M (10.46M) (8.12M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
30.36M 62.04M 54.34M 58.52M
Minority Interest Expense
- - - -
-
Net Income
30.36M 62.04M 54.34M 58.52M
Net Income Growth
-53.84% +104.35% -12.41% +7.70%
Net Margin Growth
+3.86% +5.70% +4.66% +4.54%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
30.36M 62.04M 54.34M 58.52M
Preferred Dividends
- - - -
-
Net Income Available to Common
30.36M 62.04M 54.34M 58.52M
EPS (Basic)
0.3293 0.6529 0.594 0.6832
EPS (Basic) Growth
-55.39% +98.27% -9.02% +15.02%
Basic Shares Outstanding
92.20M 95.02M 91.48M 85.65M
EPS (Diluted)
0.3037 0.6162 0.5693 0.6512
EPS (Diluted) Growth
-53.65% +102.90% -7.61% +14.39%
Diluted Shares Outstanding
99.96M 100.67M 95.45M 89.86M
EBITDA
24.94M 64.47M 70.63M 90.22M
EBITDA Growth
-25.86% +158.46% +9.56% +27.74%
EBITDA Margin
+3.17% +5.92% +6.05% +7.00%

Snapshot

Average Recommendation BUY Average Target Price 29.545
Number of Ratings 11 Current Quarters Estimate 0.333
FY Report Date 06 / 2026 Current Year's Estimate 1.279
Last Quarter’s Earnings 0.29 Median PE on CY Estimate N/A
Year Ago Earnings 0.65 Next Fiscal Year Estimate 1.483
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 10 10 10 10
Mean Estimate 0.33 0.33 1.28 1.48
High Estimates 0.37 0.36 1.36 1.80
Low Estimate 0.29 0.31 1.12 1.22
Coefficient of Variance 6.49 5.49 4.92 11.43

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 9 9 8
OVERWEIGHT 1 1 1
HOLD 1 1 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Progyny Inc - PGNY

Date Name Shares Transaction Value
Dec 5, 2025 Mark Livingston CHIEF FINANCIAL OFFICER 48,134 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $25.27 per share 1,216,346.18
Dec 5, 2025 Mark Livingston CHIEF FINANCIAL OFFICER 47,921 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $25.5 per share 1,221,985.50
Dec 5, 2025 Michael Sturmer PRESIDENT 296,210 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $25.27 per share 7,485,226.70

Progyny Inc in the News